bioAffinity (BIAF) Tops Q2 EPS by 146c

bioAffinity (NASDAQ: BIAF) reported Q2 EPS of ($0.64), $1.46 better than the analyst estimate of ($2.10). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.7 million.

For earnings history and earnings-related data on bioAffinity (BIAF) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Five earnings winners lead Friday's premarket surge
• Microsoft only US hyperscaler with positive free cash flow as AI capex bites